In April 2025, the US Food and Drug Administration (FDA) published a roadmap for leveraging new approach methodologies (NAMs), including in silico approaches such as artificial intelligence (AI), to ...

Ultra-low Latency, 64B Line-rate Switching, Lossless Fabric and In-Network Collectives Define a New Level of Performance for Ethernet in HPC and AI Scale-up ...